Type of Deal |
Value |
Acquirer |
Target |
Adviser to acquirer (tax) |
Adviser to target (tax) |
Acquisition |
$5.2 billion |
Shire |
NPS Pharmaceuticals |
Skadden, Arps, Slate, Meagher & Flom |
Davis Polk & Wardwell; Slaughter and May |
Acquisition |
$4.1 billion |
XL Group (Ireland) |
Catlin Group (Bermuda) |
Skadden, Arps, Slate, Meagher & Flom; Morgan Stanley; Goldman Sachs |
Slaughter and May; JPMorgan Chase; Evercore; Barclays |
Strategic investment |
$1.6 billion |
JD.com and Tencent Holdings |
Bitauto Holdings |
Davis Polk & Wardwell; Orrick, Herrington & Sutcliffe; Paul Weiss, Rifkind, Wharton & Garrison |
Skadden, Arps, Slate, Meagher & Flom; Sullivan & Cromwell (represented financial adviser Credit Suisse Securities) |
Acquisition |
$427 million |
Goldcorp |
Probe Mines |
Cassels Brock & Blackwell |
Stikeman Elliott - Katy Pitch |
Acquisition of a 20% stake |
$402 million |
Cathay Life Insurance |
Rizal Commercial Banking Corporation (Philippines) |
Angara Abello Concepcion Regala & Cruz; Skadden, Arps, Slate, Meagher & Flom: Jonathan Stone, Rajeev Duggal and Zachary Levine |
|
Voluntary conditional offer |
$252 million |
Southern Capital Group |
UE E&C |
ciel |
|
Acquisition of a majority (70%) stake |
$160 million |
Ctrip.com International (China) |
Travelfusion |
Skadden, Arps, Slate, Meagher & Flom: John Adebiyi and Julie Gao |
|
Acquisition |
$160 million |
Graco |
High Pressure Equipment Company from Wassertein & Co |
Skadden, Arps, Slate, Meagher & Flom; Houlihan Lokey |
|
Acquisition |
Undisclosed |
Wit.ai |
Fenwick & West |
||
Acquisition |
Undisclosed |
Silver Springs Networks |
Detectent |
Fenwick & West: Rob Freedman, Scott Joachim, Priscila Bastazin, Margaret Ding and Scott Spector |
|
Acquisition |
Undisclosed |
QuickFire Networks |
Fenwick & West: Adam Halpern, Larissa Neumann and Julia Ushakova-Stein |
||
Merger |
Undisclosed |
MeinFernBus |
FlixBus |
Hengeler Mueller: Martin Klein, Mathias Link and Steffan Neumann |
Hogan Lovells: Nikolas Zirngibl |
Acquisition |
Undisclosed |
Gilead Sciences |
Farnesoid X Receptor profram from Phenex Pharmaceuticals |
Skadden, Arps, Slate, Meagher & Flom |
CMS Hasche Sigle; Faber Daeufur & Itrato |
Type of Deal |
Value |
Issuer/Borrower |
Lead managers/ arrangers |
Adviser to issuer/ borrower (tax) |
Adviser to lead managers (tax) |
Various structured notes programme update |
$5 billion |
Itaú Unibanco SA; Itaú Unibanco, Grand Cayman branch; Itaú Unibanco New York; Itaú Unibanco Nassau branch |
Lefosse Advogados: Ricardo Bolan, Ana Clauia Couto, Carla Cardoso and Marcela Coelho |
||
Joint venture |
$3.1 billion |
Cielo and BB Elo Cartões e Participações |
Lefosse Advogados: Bruno Carramaschi and Juan Mendez |
||
Senior notes due 2025 |
$700 million |
Brixmor Operating Partnership |
Citigroup, JP Morgan Securities, Wells Fargo, Barclays Capital, Merrill Lynch, Pierce, Fenner & Smith, Deutsche Bank Securities and RBC |
Skadden, Arps, Slate, Meagher & Flom |
|
Common stock offering |
$500 million |
Medical Properties Trust Inc |
Merrill Lynch, Pierce, Fenner & Smith, J.P. Morgan, Deutsche Bank, Barclays Capital and KeyBanc Capital Markets |
Skadden, Arps, Slate, Meagher & Flom |
|
High-yield notes due 2022 |
$500 million |
Aircastle Limited |
Skadden, Arps, Slate, Meagher & Flom |
||
Secondary offering of common stock |
$455 million |
Brixmor Property Group |
JP Morgan Securities and Citigroup Global Markets |
Skadden, Arps, Slate, Meagher & Flom |